Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.130
-0.090 (-4.05%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.110 (5.16%)
After-hours: Dec 5, 2025, 7:47 PM EST
Senti Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
34
Market Cap
56.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SNTI News
- 2 days ago - Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Society of Hematology (ASH) Annual Meeting 2025 on Tuesday, December 9th at 8:00 AM ET - GlobeNewsWire
- 22 days ago - Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December - GlobeNewsWire
- 4 weeks ago - Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025 - GlobeNewsWire
- 7 weeks ago - Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 2 months ago - Senti Bio to Present at BioJapan - GlobeNewsWire
- 2 months ago - Senti Bio to Present at the MedInvest Biotech & Pharma Conference - GlobeNewsWire
- 3 months ago - Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - GlobeNewsWire